Increasing Demand For AI Powered Computing Is Fueling The Growth Of Epinephrine Market


https://www.coherentmarketinsights.com/market-insight/epinephrine-market-2401
Epinephrine Market 


Epinephrine, also known as adrenaline, is a hormone and medication. It is used to treat allergic reactions including anaphylaxis, cardiac arrest, and superficial bleeding. Epinephrine injections are easy to administer and can be life-saving in emergency situations like insect stings or bites, food allergies, and other causes of anaphylaxis. It works by constricting blood vessels, opening airways in the lungs, and regulating heart rate.


The global Epinephrine Market is estimated to be valued at US$ 1.95 Bn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
 
One of the key trends in the epinephrine market is the increasing demand for prefilled syringes and auto-injectors. Prefilled syringes and auto-injectors help patients to self-administer epinephrine during an emergency with ease of use. Advanced auto-injectors provide voice instructions to guide patients through medication administration. They also include safety mechanisms to prevent accidental injections. Many companies are focusing on developing more user-friendly and precise drug delivery devices to improve treatment outcomes of patients suffering from anaphylaxis.

Segment Analysis

The global epinephrine market is segmented into product, application, distribution channel, and region. Based on product, the epinephrine market is segregated into prefilled syringe, auto-injectors, and ampoules & vials. The auto-injector segment dominates the market and accounts for the largest revenue share owing to ease of self-administration without any training.

Key Takeaways

The global Epinephrine Market Share is expected to witness high growth, exhibiting CAGR of 11% over the forecast period, due to increasing prevalence of anaphylaxis and other allergic reactions.

Regional analysis

North America holds the major share of the global epinephrine market and is expected to continue dominating the market during the forecast period. This is attributed to increasing awareness about anaphylaxis, growing demand for epinephrine auto-injectors, and presence of key players in the region. Asia Pacific is anticipated to register the fastest growth rate over the forecast period owing to rising health expenditure, increasing healthcare infrastructure, and growing prevalence of food allergies in the region.

Key players

Key players operating in the epinephrine market are Mylan N.V., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Impax Laboratories, Inc., Kaleo, Inc., Adamis Pharmaceuticals Corporation, Bausch Health Companies, and ALK- Abello A/S. Mylan N.V. dominates the global market, accounting for the largest revenue share, due to its flagship epinephrine auto-injector brand - EpiPen.

Comments

Popular posts from this blog

Global Fiber Reinforced Concrete Market Opportunity Analysis and Industry Forecast 2028

Augmented Reality Is Fastest Growing Segment Fueling The Growth Of Air Defense Systems Market

The U.S. Sterile Injectables Market Witnessing Tremendous Growth Due to Rising Prevalence of Chronic Disease